Method for modulating macrophage activation

Details for Australian Patent Application No. 2006228064 (hide)

Owner Neurochem (International) Limited

Inventors Morrissette, Celine; Gervais, Francine

Agent Shelston IP

Pub. Number AU-B-2006228064

Parent 2002301959

Filing date 13 October 2006

Wipo publication date 2 November 2006

Acceptance publication date 17 July 2008

International Classifications

A61K 31/185 (2006.01) - Acids

A61K 31/255 (2006.01)

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

2 November 2006 Application Open to Public Inspection

  Published as AU-B-2006228064

2 November 2006 Complete Application Filed

17 July 2008 Application Accepted

  Published as AU-B-2006228064

7 August 2008 Alteration of Name

  The name of the applicant has been altered to Bellus Health (International) Limited

2 October 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Sep 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2007

11 December 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 14 Nov 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2007

29 January 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Sep 2008

2 April 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Nov 2008

9 April 2009 Standard Patent Sealed

25 August 2011 Assignment Registered

  Bellus Health (International) Limited The patent has been assigned to Bellus Health Inc.

6 September 2012 Assignment Registered

  Bellus Health Inc. The patent has been assigned to BHI Limited Partnership

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228065-Improved nucleic acid modifying enzymes

2006228063-Use of IL-1 inhibitors and TNF antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia